Irinotecan plus carboplatin in patients with extensive-disease small-cell lung cancer

By Kim Young  

Medical Oncology, Vol. 28, Iss. 1, 2011-03 ,pp. : 342-350

Humana Press, Inc

Access to resources Recommend Favorite

Chemoradiotherapy for Limited-disease Small-cell Lung Cancer in Elderly Patients Aged 75 Years or Older

By Shukuya Takehito   Takahashi Toshiaki   Harada Hideyuki   Ono Akira   Akamatsu Hiroaki   Taira Tetsuhiko   Kenmotsu Hirotsugu   Naito Tateaki   Murakami Haruyasu   Endo Masahiro   Takahashi Kazuhisa   Yamamoto Nobuyuki  

Japanese Journal of Clinical Oncology, Vol. 43, Iss. 2, 2013-02 ,pp. : 176-183

Oxford University Press

Access to resources Recommend Favorite

A Phase II Trial of Fotemustine and Cisplatin in Central Nervous System Metastases From Non-small Cell Lung Cancer

By Cotto C.   Berille J.   Souquet P.J.   Riou R.   Croisile B.   Turjman F.   Giroux B.   Brune J.   Trillet-Lenoir V.  

European Journal of Cancer, Vol. 32, Iss. 1, 1996-01 ,pp. : 69-71

Elsevier

Access to resources Recommend Favorite

A phase II study of dose-intensified weekly concomitant administration of cisplatin and irinotecan in chemonaive patients with extensive-disease small-cell lung cancer

By Han Ji-Youn   Lee Dae   Lee Sung   Park Chun   Kim Hae   Kim Eun-A   Yoon Sung   Lee Hong   Lee Jin  

Medical Oncology, Vol. 22, Iss. 3, 2005-09 ,pp. : 281-290

Humana Press, Inc

Access to resources Recommend Favorite

Factors Influencing the Distribution of Metastases and Survival in Extensive Disease Small Cell Lung Cancer

By Tas Faruk   Aydiner Adnan   Topuz Erkan   Camlica Hakan   Saip Pinar   Eralp Yesim  

Acta Oncologica, Vol. 38, Iss. 8, 1999-12 ,pp. : 1011-1015

Informa Healthcare

Access to resources Recommend Favorite